Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012552 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Davide Caredio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuropathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Muscle, Skeletal, Glutamine, Glutamic Acid, Prion Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Swiss National Science Foundation, Human Frontiers Science Program.
Abstract (Originalsprache)
In prion diseases (PrDs), aggregates of misfolded prion protein (PrP Sc ) accumulate not only in the brain but also in extraneural organs. This raises the question whether prion-specific pathologies arise also extraneurally. Here we sequenced mRNA transcripts in skeletal muscle, spleen and blood of prion-inoculated mice at eight timepoints during disease progression. We detected gene-expression changes in all three organs, with skeletal muscle showing the most consistent alterations. The glutamate-ammonia ligase ( GLUL ) gene exhibited uniform upregulation in skeletal muscles of mice infected with three distinct scrapie prion strains (RML, ME7, and 22L) and in victims of human sporadic Creutzfeldt-Jakob disease. GLUL dysregulation was accompanied by changes in glutamate/glutamine metabolism, leading to reduced glutamate levels in skeletal muscle. None of these changes were observed in skeletal muscle of humans with amyotrophic lateral sclerosis, Alzheimer’s disease, or dementia with Lewy bodies, suggesting that they are specific to prion diseases. These findings reveal an unexpected metabolic dimension of prion infections and point to a potential role for GLUL dysregulation in the glutamate/glutamine metabolism in prion-affected skeletal muscle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Neuropathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot, Israel.
- Médecin praticien hospitalier en Neuropathologie chez Hospices Civils de Lyon, France.
ORCID-Profile: Adriano Aguzzi
Förderung
- European Research Council
- Swiss National Science Foundation
- Human Frontiers Science Program
- NOMIS Stiftung
- Fondazione Gelu
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Human Frontier Science Program
Zitieren
APA
Caredio, D., Koderman, M., Frontzek, K. J., Sorce, S., Nuvolone, M., Bremer, J., Mariutti, G., Schwarz, P., Madrigal, L., Mitrovic, M., Sellitto, S., Streichenberger, N., Scheckel, C., & Aguzzi, A. (2024). Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012552
Vancouver
Caredio D, Koderman M, Frontzek KJ, Sorce S, Nuvolone M, Bremer J, et al. Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012552
BibTeX
@article{Caredio2024,
author = {Caredio, Davide and Koderman, Maruša and Frontzek, Karl J and Sorce, Silvia and Nuvolone, Mario and Bremer, Juliane and Mariutti, Giovanni and Schwarz, Petra and Madrigal, Lidia and Mitrovic, Marija and Sellitto, Stefano and Streichenberger, Nathalie and Scheckel, Claudia and Aguzzi, Adriano},
title = {Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012552}
}
EUVIMED